Literature DB >> 3677297

Concurrent allopurinol and 5-fluorouracil: 5-fluoro-2'-deoxyuridylate formation and thymidylate synthase inhibition in rat colon carcinoma and in regenerating rat liver.

M Berne1, B Gustavsson, O Almersjö, C P Spears, J Waldenström.   

Abstract

The formation of FdUMP and the inhibition of TS were studied in a subcutaneously growing transplantable rat colon carcinoma and in regenerating rat liver following bolus administration of 5-FU, with or without HPP pretreatment. In tumor, peak levels of FdUMP at 30 min following bolus 5-FU, 100 mg/kg, averaged 4931 +/- 587 pmol/g. Pretreatment with HPP, 50 mg/kg, 24 h and 1 h before 5-FU, reduced the peak FdUMP level to 2085 +/- 387 pmol/g. The inhibition of TS by 5-FU treatment was greater than 95% by 30 min, and after 48 h residual enzyme inhibition averaged 40%. No effect on TS inhibition by 5-FU treatment could be observed as a result of HPP pretreatment. The levels of TStot increased linearly after 5-FU treatment and doubled within 48 h. In regenerating rat liver, neither FdUMP levels nor TS inhibition, studied at 1 h after bolus 5-FU, were affected by HPP pretreatment.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3677297     DOI: 10.1007/bf00570483

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  24 in total

1.  Thymidylate synthetase: mechanism of inhibition by 5-fluoro-2'-deoxyuridylate.

Authors:  R J Langenbach; P V Danenberg; C Heidelberger
Journal:  Biochem Biophys Res Commun       Date:  1972-09-26       Impact factor: 3.575

2.  Methods for the separation and identification of ribonucleotides on DEAE-cellulose.

Authors:  Y M Rustum; H S Schwartz
Journal:  Anal Biochem       Date:  1973-06       Impact factor: 3.365

3.  An improved procedure for extraction and analysis of cellular nucleotides.

Authors:  R N Nazar; H G Lawford; J T Wong
Journal:  Anal Biochem       Date:  1970-06       Impact factor: 3.365

Review 4.  The pharmacology of the fluoropyrimidines.

Authors:  C E Myers
Journal:  Pharmacol Rev       Date:  1981-03       Impact factor: 25.468

5.  5-Fluorouracil in combination with hypoxathine and allopurinol: toxicity and metabolism in xenografts of human colonic carcinomas in mice.

Authors:  J A Houghton; P J Houghton
Journal:  Biochem Pharmacol       Date:  1980-07-15       Impact factor: 5.858

6.  Selective antagonism of 5-fluorouracil cytotoxicity by 4-hydroxypyrazolopyrimidine (allopurinol) in vitro.

Authors:  P M Schwartz; R E Handschumacher
Journal:  Cancer Res       Date:  1979-08       Impact factor: 12.701

7.  Intravesical high dose 5-fluorouracil instillations combined with allopurinol--a therapeutic alternative in the treatment of multiple bladder tumors.

Authors:  K H Leissner; B Gustavsson
Journal:  J Urol       Date:  1984-07       Impact factor: 7.450

8.  Allopurinol mouthwashes and 5-fluorouracil induced oral toxicity.

Authors:  P I Clark; M L Slevin
Journal:  Eur J Surg Oncol       Date:  1985-09       Impact factor: 4.424

9.  Modulation of 5-fluorouracil toxicity by allopurinol in man.

Authors:  S B Howell; W E Wung; R Taetle; F Hussain; J S Romine
Journal:  Cancer       Date:  1981-09-15       Impact factor: 6.860

10.  Allopurinol modulation of fluorouracil toxicity.

Authors:  R M Fox; R L Woods; M H Tattersall; A A Piper; D Sampson
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

View more
  2 in total

Review 1.  Systematic review of miscellaneous agents for the management of oral mucositis in cancer patients.

Authors:  Siri Beier Jensen; Virginia Jarvis; Yehuda Zadik; Andrei Barasch; Anura Ariyawardana; Allan Hovan; Noam Yarom; Rajesh V Lalla; Joanne Bowen; Sharon Elad
Journal:  Support Care Cancer       Date:  2013-07-31       Impact factor: 3.603

2.  Prediction of 5-fluorouracil cytotoxicity towards the Walker carcinosarcoma using peak integrals of fluoronucleotides measured by MRS in vivo.

Authors:  P M McSheehy; M J Prior; J R Griffiths
Journal:  Br J Cancer       Date:  1989-09       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.